주식/증권
📈 긍정적
RVTY Expands Endocrine Diagnostics With FDA-Cleared Testosterone Assay
요약
Revvity gains FDA clearance for IDS' Total Testosterone assay, expanding its automated endocrine testing platform for reproductive diagnostics.